Frier Levitt is proud to announce that the firm has been selected for inclusion in the Chambers USA Spotlight Guide: New York 2026 for Healthcare Law by Chambers and Partners. This recognition reflects the firm’s deep industry knowledge and longstanding commitment to supporting healthcare providers, innovators, and organizations nationwide.
This guide highlights the top boutique firms across New York, representing practices from sole practitioners to firms of up to 75 attorneys. Only about 2% of the market achieves this recognition, making Frier Levitt’s inclusion especially meaningful and exclusive.
The acknowledgment highlights Frier Levitt’s track record of delivering strategic counsel and meaningful results across the healthcare sector. The firm represents clients in complex regulatory and compliance matters, healthcare transactions, PBM disputes, reimbursement challenges, government investigations, and litigation affecting providers and life sciences companies throughout the country.
Chambers and Partners, one of the world’s most respected independent legal research organizations, ranks leading law firms and lawyers across more than 200 jurisdictions. The Spotlight designation is awarded to select small and mid-sized firms that demonstrate significant strengths, notable achievements, and exceptional client service.
This ranking reinforces Frier Levitt’s role as a trusted advisor in the healthcare legal landscape, recognized for its innovative perspectives, strong advocacy, and understanding of the evolving challenges facing today’s healthcare organizations.
About Frier Levitt
Frier Levitt is a national healthcare and life sciences law firm delivering strategic guidance to providers, pharmacies, life sciences companies, and healthcare organizations. The firm brings together regulatory insight, litigation strength, and industry-specific experience to help clients navigate complex legal challenges, protect their operations, and position their businesses for long-term success.
Please see Chambers and Partners Methodology. No aspect of this advertisement has been approved by the Supreme Court of New Jersey. Prior results do not guarantee a similar outcome.
